Kamada (KMDA) EBT Margin (2012 - 2026)
Kamada (KMDA) posted quarterly EBT Margin of 11.92% for Q1 2026, down 311.0% year-on-year from 5.65% in Q1 2025, and up 12.46% on a QoQ basis from 10.6% in Q4 2025.
Kamada (KMDA) EBT Margin (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported EBT Margin for 15 consecutive years, with 11.92% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin fell 311.0% year-over-year to 11.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 1.0% YoY) and the FY2025 annual result came in at 13.0%, up 472.0% from the prior year.
- EBT Margin rose to 11.92% in Q1 2026 per KMDA's latest filing, from 10.6% in the prior quarter.
- Over the last five years, EBT Margin for KMDA reached as high as 16.77% in Q2 2022 and fell as low as 0.0% in Q1 2023.
- A 5-year average of 7.73% and a median of 7.15% in 2022 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin surged 2246 bps — and 2023, when it plunged 1168 bps.
- Year by year, EBT Margin stood at 7.15% in 2022, then soared by 93 bps to 13.79% in 2023, then tumbled by 54 bps to 6.3% in 2024, then jumped by 68 bps to 10.6% in 2025, then increased by 12 bps to 11.92% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 11.92%, 10.6%, and 13.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 11.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.92% |
| Dec 31, 2025 | 10.60% |
| Sep 30, 2025 | 13.54% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 15.02% |
| Dec 31, 2024 | 6.30% |
| Sep 30, 2024 | 9.46% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 6.46% |
| Dec 31, 2023 | 13.79% |
| Sep 30, 2023 | 8.69% |
| Jun 30, 2023 | 5.09% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 7.15% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 16.77% |
| Mar 31, 2022 | 6.66% |
| Dec 31, 2021 | -15.31% |
| Sep 30, 2021 | 3.77% |
| Jun 30, 2021 | 3.98% |